Group | Lp(a) (mg/dl) | Prevalence of Lp(a) > 30 mg/dl |
Controls (n=17) | 16.9 (12.1) (median 10.7) | 17.6 |
Behcet's disease patients (n=27) | 27.2 (21.1)1-150 (median 20.3) | 44.41-160 |
Presence (n) | Absence (n) | |
Active disease | 28.4 (19) (n=10) | 26.5 (20.1) (n=17) |
Ocular involvement | 30.3 (19.2) (n=14)1-150 | 24.3 (20.0) (n=13) |
Skin lesions | 40.7 (43.1) (n=12)1-150 | 16.4 (14.1) (n=15) |
Arthritis/arthralgia | 24.7 (15.4) (n=10)1-150 | 34.1 (23) (n=17) |
Neurologic involvement | 35.2 (16.6) (n=3)1-150 | 26.2 (20.4) (n=24) |